85 related articles for article (PubMed ID: 8429253)
21. [The comparison of absorptive routes of intraperitoneal infusion with cisplatin in dogs].
Namatame K; Kou Y; Sasaki E; Nakayoshi A
Gan To Kagaku Ryoho; 1992 Aug; 19(10 Suppl):1716-9. PubMed ID: 1530339
[TBL] [Abstract][Full Text] [Related]
22. [Pharmacokinetic analysis of low-dose intra-peritoneal cis-platinum administration].
Terashima M; Ikeda K; Takagane A; Sasaki N; Abe K; Araya M; Nishizuka S; Yonezawa H; Irinoda T; Nakaya T; Oyama K; Saito K
Gan To Kagaku Ryoho; 1998 Jul; 25(9):1433-5. PubMed ID: 9703846
[TBL] [Abstract][Full Text] [Related]
23. [High-dose CDDP therapy using a balloon-occluded arterial infusion (BOAI) in recurrent ovarian cancer].
Suzumori K; Yasui Y; Yagami Y; Mimura M; Banno T; Nakamura T
Gan No Rinsho; 1988 Aug; 34(9):1107-14. PubMed ID: 3172517
[TBL] [Abstract][Full Text] [Related]
24. [The hypertensive effect induced with angiotensin II and the physiological and pharmacokinetic aspects of two-route chemotherapy using CDDP and STS].
Takizawa K; Harada M; Fujimaru J; Shima Y; Yokoo I; Ozaki I; Sato M; Iguchi T; Takeda Y
Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 2):1569-74. PubMed ID: 2389950
[TBL] [Abstract][Full Text] [Related]
25. [The value of a Tenckhoff catheter in ovarian cancer].
Kato N; Arakawa A; Yasui Y; Suzumori K; Suzumori K; Yagami Y
Gan To Kagaku Ryoho; 1991 May; 18(6):1025-30. PubMed ID: 2029187
[TBL] [Abstract][Full Text] [Related]
26. [Intraperitoneal (Ip) administration of cisplatin in combination with systemic chemotherapy in patients with malignant ascites of gastrointestinal cancer: clinical evaluation and pharmacokinetics].
Koda K; Nakazawa O; Terada S; Kure T; Morita K; Hirayama M; Fukushi A; Terui T; Yoshizaki N; Takahashi H
Gan No Rinsho; 1988 Feb; 34(2):191-5. PubMed ID: 3126333
[TBL] [Abstract][Full Text] [Related]
27. [Intraperitoneal versus intravenous infusion of cis-platinum in advanced ovarian cancer--examination of pharmacokinetics].
Shindo K; Oikawa N; Atsumi Y; Chida S; Tuburaya T; Yajima A
Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 1):639-44. PubMed ID: 3827260
[TBL] [Abstract][Full Text] [Related]
28. Intraperitoneal cisplatin and intravenous paclitaxel in the treatment of epithelial ovarian cancer patients with a positive second look.
Makhija S; Sabbatini P; Aghajanian C; Venkatraman E; Spriggs DR; Barakat R
Gynecol Oncol; 2000 Oct; 79(1):28-32. PubMed ID: 11006026
[TBL] [Abstract][Full Text] [Related]
29. [Augmentative effects of radiofrequency hyperthermia (RFH) combined with intraperitoneal (IP) administration of CDDP in ovarian cancer].
Ino Y; Takizawa K; Isono T; Sato M; Yokoo I; Iguchi T; Takeda Y; Yokoyama M
Gan To Kagaku Ryoho; 1988 Jun; 15(6):1887-91. PubMed ID: 3382241
[TBL] [Abstract][Full Text] [Related]
30. [Intraperitoneal (i.p.) chemotherapy in the management of ovarian cancer--pharmacokinetics and methods of sequential i.p. chemotherapy].
Noda T; Adachi S; Yamamoto T; Hirooka C; Kiyozuka Y; Adachi S; Oku M; Ichijo M
Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 2):1561-8. PubMed ID: 2389949
[TBL] [Abstract][Full Text] [Related]
31. [Usefulness of intraperitoneal carboplatin administration-- pharmacokinetic analysis].
Ito K; Itani Y; Furuki K; Tamori N; Noda T; Adachi S; Hirano Y; Kato Y; Kiyozuka Y
Nihon Sanka Fujinka Gakkai Zasshi; 1992 Sep; 44(9):1180-6. PubMed ID: 1453047
[TBL] [Abstract][Full Text] [Related]
32. [Studies on an appropriate intra thoracic administration of cisplatin and sodium thiosulfate in malignant pleural effusion].
Kitajima K; Fukuoka M; Kusunoki Y; Negoro S; Takada M; Matsui K; Sakai N; Ryu S; Takifuji N; Masuda N
Gan To Kagaku Ryoho; 1988 Dec; 15(12):3253-9. PubMed ID: 3196043
[TBL] [Abstract][Full Text] [Related]
33. Population pharmacokinetics of cisplatin in patients with advanced ovarian cancer during intraperitoneal hyperthermia chemotherapy.
Panteix G; Beaujard A; Garbit F; Chaduiron-Faye C; Guillaumont M; Gilly F; Baltassat P; Bressolle F
Anticancer Res; 2002; 22(2B):1329-36. PubMed ID: 12168946
[TBL] [Abstract][Full Text] [Related]
34. A phase I trial of intraperitoneal sustained-release paclitaxel microspheres (Paclimer) in recurrent ovarian cancer: a Gynecologic Oncology Group study.
Armstrong DK; Fleming GF; Markman M; Bailey HH
Gynecol Oncol; 2006 Nov; 103(2):391-6. PubMed ID: 16626792
[TBL] [Abstract][Full Text] [Related]
35. Intraperitoneal versus intravenous cisplatin in combination with intravenous cyclophosphamide and epidoxorubicin in optimally cytoreduced advanced epithelial ovarian cancer: a randomized trial of the Gruppo Oncologico Nord-Ovest.
Gadducci A; Carnino F; Chiara S; Brunetti I; Tanganelli L; Romanini A; Bruzzone M; Conte PF
Gynecol Oncol; 2000 Feb; 76(2):157-62. PubMed ID: 10637064
[TBL] [Abstract][Full Text] [Related]
36. [Renal toxicity by intraperitoneal administration of CDDP].
Chen JT; Yamashiro T; Shimizu Y; Kuo TC; Nakayama K; Teshima H; Hirai Y; Hamada T; Fujimoto I; Yamauchi K
Nihon Sanka Fujinka Gakkai Zasshi; 1988 May; 40(5):534-40. PubMed ID: 3385274
[TBL] [Abstract][Full Text] [Related]
37. [Significance and effects of intraperitoneal cisplatin administration for ovarian cancer].
Shimizu A; Ookubo K; Hasegawa J; Endoh T; Fujiwara O; Yoda A; Okuyama D; Narabayashi A; Kimura T; Takahashi J; Notake Y
Gan To Kagaku Ryoho; 1999 Oct; 26(12):1801-5. PubMed ID: 10560398
[TBL] [Abstract][Full Text] [Related]
38. Health-related quality of life during and after intraperitoneal versus intravenous chemotherapy for optimally debulked ovarian cancer: a Gynecologic Oncology Group Study.
Wenzel LB; Huang HQ; Armstrong DK; Walker JL; Cella D;
J Clin Oncol; 2007 Feb; 25(4):437-43. PubMed ID: 17264340
[TBL] [Abstract][Full Text] [Related]
39. [Local injection of high-dose CDDP to the advanced gynecological cancer].
Hashii K; Takahashi A; Kanto T; Ukita M; Tateyama I; Natsuyama S; Mori T
Nihon Gan Chiryo Gakkai Shi; 1990 Jul; 25(7):1472-81. PubMed ID: 2212837
[TBL] [Abstract][Full Text] [Related]
40. Ip cisplatin in patients with malignant ascites: pharmacokinetic evaluation and comparison with the iv route.
Casper ES; Kelsen DP; Alcock NW; Lewis JL
Cancer Treat Rep; 1983 Mar; 67(3):235-8. PubMed ID: 6682012
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
